Jubilant's new allergens facility makes progress - Spokane Journal of Business

Jubilant to expand campus with $18.5M allergens facility

Spokane-based pharmaceutical manufacturing and packaging company Jubliant HollisterStier LLC plans to expand its campus footprint with the addition of a new $18.5 million building to relocate its allergens processing business unit, says Jennifer Beeler, director of marketing for HollisterStier Allergy.

The proposed two-story structure is planned for two parcels of land totaling nearly an acre in size, at 2813 and 2835 E. Gordon, which Beeler indicates is just north of the existing Jubliant HollisterStier campus in Spokane's Bemiss neighborhood, at 3525 N. Regal.

This proposed development is the first phase of a multi-phase expansion of the company’s existing allergy manufacturing facility, Beeler emphasizes.

“At some point, this will all essentially be part of the main campus,” Beeler says. “It will not be a separate standalone facility or area; it will be an expansion of the JHS campus we currently have.”

The two parcels of land for the project were purchased in October for $650,000 by Jubliant HollisterStier, according to Spokane County tax records.

Lydig Construction Inc. is the contractor for the project. An architect has not yet been determined.

The proposed new structure will house HollisterStier Allergy’s raw materials, compounding functions, biological source materials storage, and research and development laboratory space, according to a predevelopment application. The facility will also include cleanroom spaces, mechanical support areas, offices, and acetone and solvent storage areas.

HollisterStier Allergy was founded in 1921 in Spokane by Guy Hollister and Dr. Robert Stier with a focus on relieving allergy sufferers. Jubliant HollisterStier, the contract manufacturer of injectable products, was founded in 1999. Both are separate business units within Jubliant HollisterStier LLC, a subsidiary of India-based Jubliant Pharmova Limited.

Starting in 2021, Jubliant HollisterStier embarked on a multi-phase $285 million expansion of its contract manufacturing injectable product lines. In 2024, the company opened its third sterile finish manufacturing line, valued at $92 million, including a high-speed commercial finish line capable of delivering 400 vials per minute and increasing production capacity by 55 million units annually.

A second phase of expansion is already underway and is scheduled for completion in mid-2026. This phase will include a fourth line at the manufacturing plant, mirroring the capabilities of the third line, with advanced isolator technology and high-speed sterile fill-finish capacity.

As of Dec. 12, Jubliant HollisterStier had over 1,100 full-time employees, according to the Spokane Journal's latest Spokane County's Largest Employers list.

Leave a Reply